OrthoPediatrics (NASDAQ:KIDS) Releases Earnings Results, Beats Estimates By $0.06 EPS

Key Points

• OrthoPediatrics reported earnings of ($0.11) per share, surpassing the expected ($0.17) EPS by $0.06.
• Shares fell by 1.7% to $20.19, with a market capitalization of $490.42 million and trading volume above its average.
• Despite recent mixed analyst ratings, the company has a consensus rating of "Moderate Buy" with an average price target of $35.83.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.11) EPS for the quarter, topping analysts' consensus estimates of ($0.17) by $0.06, Zacks reports. OrthoPediatrics had a negative net margin of 18.92% and a negative return on equity of 6.35%. The business had revenue of $61.08 million during the quarter, compared to analysts' expectations of $61.40 million. OrthoPediatrics updated its FY 2025 guidance to EPS.

OrthoPediatrics Trading Down 1.5%

KIDS traded down $0.29 on Friday, reaching $18.91. 157,582 shares of the company traded hands, compared to its average volume of 186,890. OrthoPediatrics has a one year low of $16.59 and a one year high of $33.14. The firm has a fifty day simple moving average of $21.38 and a two-hundred day simple moving average of $22.64. The company has a market cap of $474.07 million, a P/E ratio of -10.56 and a beta of 1.12. The company has a quick ratio of 2.99, a current ratio of 6.19 and a debt-to-equity ratio of 0.21.

Institutional Investors Weigh In On OrthoPediatrics

A number of institutional investors and hedge funds have recently added to or reduced their stakes in KIDS. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in OrthoPediatrics by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock valued at $246,000 after buying an additional 645 shares in the last quarter. Millennium Management LLC increased its position in OrthoPediatrics by 55.3% during the 1st quarter. Millennium Management LLC now owns 656,578 shares of the company's stock valued at $16,172,000 after purchasing an additional 233,873 shares during the period. Goldman Sachs Group Inc. increased its position in OrthoPediatrics by 112.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company's stock valued at $4,937,000 after purchasing an additional 106,041 shares during the period. Finally, Jane Street Group LLC purchased a new position in OrthoPediatrics during the 1st quarter valued at about $389,000. Institutional investors own 69.05% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Wall Street Zen raised shares of OrthoPediatrics from a "sell" rating to a "hold" rating in a research note on Saturday. Needham & Company LLC reissued a "buy" rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research note on Thursday, May 8th. Truist Financial lowered their target price on shares of OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a report on Friday, April 11th. JMP Securities set a $35.00 target price on shares of OrthoPediatrics and gave the stock a "market outperform" rating in a report on Friday. Finally, Citigroup restated a "market outperform" rating on shares of OrthoPediatrics in a report on Friday. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, OrthoPediatrics currently has an average rating of "Moderate Buy" and a consensus price target of $34.14.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.